Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient.
Nancy LawCathy LoganGordon YungCarrie-Lynn Langlais FurrSusan M LehmanSandra MoralesFrancisco RosasAlexander GaidamakaIgor BilinskyPaul GrintRobert T SchooleySaima AslamPublished in: Infection (2019)
Given the concern for MDR P. aeruginosa infections in CF patients, BT may offer a viable anti-infective adjunct to traditional antibiotic therapy.
Keyphrases
- cystic fibrosis
- pseudomonas aeruginosa
- multidrug resistant
- end stage renal disease
- acinetobacter baumannii
- chronic kidney disease
- ejection fraction
- newly diagnosed
- drug resistant
- lung function
- gram negative
- prognostic factors
- escherichia coli
- staphylococcus aureus
- chronic obstructive pulmonary disease
- bone marrow
- klebsiella pneumoniae
- combination therapy
- smoking cessation